多肽出海首战告捷！FDA首仿引爆业绩，上半年利润扭亏，收入飙涨115%

Core Viewpoint - The innovative drug sector, particularly the peptide drug market, is experiencing significant growth, driven by increasing demand and successful product approvals [5][7]. Group 1: Market Trends - The global peptide drug market is projected to grow at a compound annual growth rate (CAGR) of 12.5% from 2020 to 2023, indicating a sustained demand in this field [5]. - In China, the peptide drug market is expected to reach $26.7 billion by 2028, with a CAGR of 15.3% from 2023 to 2028, significantly outpacing the global average growth rate [5]. Group 2: Product and Industry Insights - Peptide drugs, composed of 10-50 amino acids, are synthesized through chemical processes or extracted from plants and animals, offering higher activity and selectivity compared to small molecule drugs [7]. - The advantages of peptide drugs include better stability, higher purity, and relatively lower production costs compared to protein drugs [8]. - Since 2021, the peptide drug sector has seen a surge, with multiple peptide drugs receiving market approval, including the notable sales of $20 billion for semaglutide in 2023 [8].